Healthcare -
Biotechnology - NASDAQ - US
$ 3.53
-0.843 %
$ 32.6 M
Market Cap
-0.56
P/E
SABS - TOTAL EQUITY
Total Equity SABS - SAB Biotherapeutics, Inc.
57.3 M
LAST VALUE
21.92%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR